Prelude Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,360
| Closed | -$251K | – | 1142 |
|
|
2024
Q4 | $251K | Buy |
+1,360
| New | +$251K | 0.02% | 765 |
|
|
2024
Q3 | – | Sell |
-3,255
| Closed | -$672K | – | 1219 |
|
|
2024
Q2 | $672K | Sell |
3,255
-3,487
| -52% | -$720K | 0.05% | 364 |
|
|
2024
Q1 | $1.83M | Buy |
6,742
+1,464
| +28% | +$397K | 0.1% | 230 |
|
|
2023
Q4 | $1.25M | Buy |
+5,278
| New | +$1.25M | 0.08% | 213 |
|
|
2023
Q1 | – | Sell |
-3,235
| Closed | -$705K | – | 1129 |
|
|
2022
Q4 | $705K | Buy |
3,235
+2,197
| +212% | +$479K | 0.04% | 412 |
|
|
2022
Q3 | $204K | Sell |
1,038
-198
| -16% | -$38.9K | 0.01% | 1037 |
|
|
2022
Q2 | $264K | Sell |
1,236
-1,305
| -51% | -$279K | 0.01% | 960 |
|
|
2022
Q1 | $722K | Buy |
+2,541
| New | +$722K | 0.02% | 549 |
|
|
2019
Q2 | – | Sell |
-56
| Closed | -$8K | – | 1327 |
|
|
2019
Q1 | $8K | Hold |
56
| – | – | ﹤0.01% | 1122 |
|
|
2018
Q4 | $6K | Buy |
+56
| New | +$6K | ﹤0.01% | 1163 |
|
|
2017
Q4 | – | Sell |
-3,039
| Closed | -$328K | – | 1271 |
|
|
2017
Q3 | $328K | Buy |
3,039
+477
| +19% | +$51.5K | 0.03% | 440 |
|
|
2017
Q2 | $259K | Sell |
2,562
-327
| -11% | -$33.1K | 0.02% | 446 |
|
|
2017
Q1 | $260K | Sell |
2,889
-139
| -5% | -$12.5K | 0.02% | 433 |
|
|
2016
Q4 | $231K | Buy |
3,028
+1,305
| +76% | +$99.6K | 0.03% | 494 |
|
|
2016
Q3 | $144K | Buy |
+1,723
| New | +$144K | 0.02% | 623 |
|
|
2016
Q1 | – | Sell |
-1,111
| Closed | -$89K | – | 1222 |
|
|
2015
Q4 | $89K | Buy |
1,111
+911
| +456% | +$73K | 0.01% | 800 |
|
|
2015
Q3 | $13K | Sell |
200
-5,689
| -97% | -$370K | ﹤0.01% | 1228 |
|
|
2015
Q2 | $414K | Hold |
5,889
| – | – | 0.06% | 325 |
|
|
2015
Q1 | $467K | Buy |
+5,889
| New | +$467K | 0.06% | 350 |
|
|
2014
Q1 | – | Sell |
-180
| Closed | -$10K | – | 1707 |
|
|
2013
Q4 | $10K | Buy |
180
+80
| +80% | +$4.44K | ﹤0.01% | 1394 |
|
|
2013
Q3 | $5K | Buy |
+100
| New | +$5K | ﹤0.01% | 1335 |
|